{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:46:06Z","timestamp":1785872766954,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s13555-024-01287-w","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:02:09Z","timestamp":1729242129000},"page":"3033-3046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Efficacy and Tolerability of an Emollient Containing Glycerol and Paraffin for Moderate-to-Severe Uremic Xerosis: A Randomized Phase\u00a03 Study"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6342","authenticated-orcid":false,"given":"Jacek C.","family":"Szepietowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2119-9501","authenticated-orcid":false,"given":"Lajos","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-0184","authenticated-orcid":false,"given":"Thomas","family":"Mettang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4800-5877","authenticated-orcid":false,"given":"Petr","family":"Arenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"11","key":"1287_CR1","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/ndt\/gfh480","volume":"19","author":"JC Szepietowski","year":"2004","unstructured":"Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis. Nephrol Dial Transplant. 2004;19(11):2709\u201312. https:\/\/doi.org\/10.1093\/ndt\/gfh480.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1287_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2340\/00015555-1075","volume":"91","author":"JC Szepietowski","year":"2011","unstructured":"Szepietowski JC, Balaskas E, Taube KM, Taberly A, Dupuy P. Quality of life in patients with uraemic xerosis and pruritus. Acta Derm Venereol. 2011;91(3):313\u20137. https:\/\/doi.org\/10.2340\/00015555-1075.","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"1287_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1346-8138.2002.tb00191.x","volume":"29","author":"JC Szepietowski","year":"2002","unstructured":"Szepietowski JC, Sikora M, Kusztal M, Salomon J, Magott M, Szepietowski T. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol. 2002;29(10):621\u20137. https:\/\/doi.org\/10.1111\/j.1346-8138.2002.tb00191.x.","journal-title":"J Dermatol"},{"issue":"9","key":"1287_CR4","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.ekir.2022.06.015","volume":"7","author":"CM Rhee","year":"2022","unstructured":"Rhee CM, Edwards D, Ahdoot RS, et al. Living well with kidney disease and effective symptom management: consensus conference proceedings. Kidney Int Rep. 2022;7(9):1951\u201363. https:\/\/doi.org\/10.1016\/j.ekir.2022.06.015.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"1287_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ckj\/sfac187","volume":"16","author":"R Agarwal","year":"2023","unstructured":"Agarwal R, Burton J, Gallieni M, et al. Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus. Clin Kidney J. 2023;16(1):30\u201340. https:\/\/doi.org\/10.1093\/ckj\/sfac187.","journal-title":"Clin Kidney J"},{"issue":"Suppl 7","key":"1287_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ddg.13906","volume":"17","author":"M Augustin","year":"2019","unstructured":"Augustin M, Wilsmann-Theis D, K\u00f6rber A, et al. Diagnosis and treatment of xerosis cutis\u2014a position paper. J Dtsch Dermatol Ges. 2019;17(Suppl 7):3\u201333. https:\/\/doi.org\/10.1111\/ddg.13906.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1287_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2147\/tcrm.S310550","volume":"17","author":"K \u015awierczy\u0144ska","year":"2021","unstructured":"\u015awierczy\u0144ska K, Bia\u0142ynicki-Birula R, Szepietowski JC. Chronic intractable pruritus in chronic kidney disease patients: prevalence, impact, and management challenges\u2014a narrative review. Ther Clin Risk Manag. 2021;17:1267\u201382. https:\/\/doi.org\/10.2147\/tcrm.S310550.","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"1287_CR8","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1093\/ndt\/gfm375","volume":"22","author":"G Yosipovitch","year":"2007","unstructured":"Yosipovitch G, Duque MI, Patel TS, et al. Skin barrier structure and function and their relationship to pruritus in end-stage renal disease. Nephrol Dial Transplant. 2007;22(11):3268\u201372. https:\/\/doi.org\/10.1093\/ndt\/gfm375.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1287_CR9","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/oxfordjournals.ndt.a027092","volume":"11","author":"CA Morton","year":"1996","unstructured":"Morton CA, Lafferty M, Hau C, Henderson I, Jones M, Lowe JG. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant. 1996;11(10):2031\u20136. https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a027092.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1287_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.nephro.2022.05.002","volume":"18","author":"PC Chang","year":"2022","unstructured":"Chang PC, Liao IC. Hydration, barrier of skin and uremic pruritus in patients undergoing hemodialysis: a pilot investigation. Nephrol Ther. 2022;18(6):498\u2013505. https:\/\/doi.org\/10.1016\/j.nephro.2022.05.002.","journal-title":"Nephrol Ther"},{"issue":"7","key":"1287_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2340\/00015555-2454","volume":"96","author":"E Wojtowicz-Prus","year":"2016","unstructured":"Wojtowicz-Prus E, Kili\u015b-Pstrusi\u0144ska K, Reich A, et al. Chronic kidney disease-associated pruritus in children. Acta Derm Venereol. 2016;96(7):938\u201342. https:\/\/doi.org\/10.2340\/00015555-2454.","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"1287_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/toxins13070450","volume":"13","author":"R Reszke","year":"2021","unstructured":"Reszke R, Kili\u015b-Pstrusi\u0144ska K, Szepietowski JC. Chronic kidney disease-associated itch (CKD-aI) in children\u2014a narrative review. Toxins (Basel). 2021;13(7):450. https:\/\/doi.org\/10.3390\/toxins13070450.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"1287_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2133.2008.08643.x","volume":"159","author":"JW Fluhr","year":"2008","unstructured":"Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions. Br J Dermatol. 2008;159(1):23\u201334. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08643.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1287_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000246112","volume":"194","author":"W Wigger-Alberti","year":"1997","unstructured":"Wigger-Alberti W, Elsner P. Petrolatum prevents irritation in a human cumulative exposure model in vivo. Dermatology. 1997;194(3):247\u201350. https:\/\/doi.org\/10.1159\/000246112.","journal-title":"Dermatology"},{"issue":"6","key":"1287_CR15","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/jocd.13163","volume":"19","author":"L Vaillant","year":"2020","unstructured":"Vaillant L, Georgescou G, Rivollier C, Delarue A. Combined effects of glycerol and petrolatum in an emollient cream: a randomized, double-blind, crossover study in healthy volunteers with dry skin. J Cosmet Dermatol. 2020;19(6):1399\u2013403. https:\/\/doi.org\/10.1111\/jocd.13163.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"1287_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/ijd.13454","volume":"56","author":"F Boralevi","year":"2017","unstructured":"Boralevi F, Meledie N\u2019Djong AP, Yao Yoboue P, et al. Regression of cutaneous xerosis with emollient treatment in sub-Saharan African patients. Int J Dermatol. 2017;56(4):467\u201373. https:\/\/doi.org\/10.1111\/ijd.13454.","journal-title":"Int J Dermatol"},{"issue":"11","key":"1287_CR17","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/jdv.12314","volume":"28","author":"F Boralevi","year":"2014","unstructured":"Boralevi F, Saint Aroman M, Delarue A, et al. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014;28(11):1456\u201362. https:\/\/doi.org\/10.1111\/jdv.12314.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1287_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/pde.13113","volume":"34","author":"GS Tiplica","year":"2017","unstructured":"Tiplica GS, Kaszuba A, Malinauskien\u0117 L, et al. Prevention of flares in children with atopic dermatitis with regular use of an emollient containing glycerol and paraffin: a randomized controlled study. Pediatr Dermatol. 2017;34(3):282\u20139. https:\/\/doi.org\/10.1111\/pde.13113.","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"1287_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/jdv.14849","volume":"32","author":"GS Tiplica","year":"2018","unstructured":"Tiplica GS, Boralevi F, Konno P, et al. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study. J Eur Acad Dermatol Venereol. 2018;32(7):1180\u20137. https:\/\/doi.org\/10.1111\/jdv.14849.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1287_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.23736\/s0392-0488.18.06078-9","volume":"153","author":"A Cristaudo","year":"2018","unstructured":"Cristaudo A, Lupi F, Mariano M, Cianchini G, De Rocco M, De Pit\u00e0 O. Clinical and instrumental evaluation of the efficacy of an emollient cream and a cleansing cream in the management of mild to moderate adulthood atopic dermatitis. G Ital Dermatol Venereol. 2018;153(6):855\u20139. https:\/\/doi.org\/10.23736\/s0392-0488.18.06078-9.","journal-title":"G Ital Dermatol Venereol"},{"key":"1287_CR21","first-page":"664","volume":"19","author":"C Blanchet-Bardon","year":"2000","unstructured":"Blanchet-Bardon C, Parmentier L, Pibourdin J, Dupuy P. Evaluation of efficacy and safety of Dexeryl\u00ae cream in symptomatic treatment of ichthyosis in a single blinded randomised comparative study. Nouv Dermatol. 2000;19:664\u20138.","journal-title":"Nouv Dermatol"},{"issue":"8","key":"1287_CR22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1468-3083.2011.04304.x","volume":"26","author":"C Blanchet-Bardon","year":"2012","unstructured":"Blanchet-Bardon C, Tadini G, Machado Matos M, Delarue A. Association of glycerol and paraffin in the treatment of ichthyosis in children: an international, multicentric, randomized, controlled, double-blind study. J Eur Acad Dermatol Venereol. 2012;26(8):1014\u20139. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04304.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1287_CR23","first-page":"179","volume":"146","author":"A Pacifico","year":"2011","unstructured":"Pacifico A, Leone G. Evaluation of a skin protection cream for dry skin in patients undergoing narrow band UVB phototherapy for psoriasis vulgaris. G Ital Dermatol Venereol. 2011;146(3):179\u201383.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"1287_CR24","first-page":"297","volume":"150","author":"A Cristaudo","year":"2015","unstructured":"Cristaudo A, Francesconi L, Ambrifi M, Frasca M, Cavallotti C, Sperduti E. Efficacy of an emollient dermoprotective cream in the treatment of elderly skin affected by xerosis. G Ital Dermatol Venereol. 2015;150(3):297\u2013302.","journal-title":"G Ital Dermatol Venereol"},{"issue":"4","key":"1287_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/jdv.14095","volume":"31","author":"J Martini","year":"2017","unstructured":"Martini J, Huertas C, Turlier V, Saint-Martory C, Delarue A. Efficacy of an emollient cream in the treatment of xerosis in diabetic foot: a double-blind, randomized, vehicle-controlled clinical trial. J Eur Acad Dermatol Venereol. 2017;31(4):743\u20137. https:\/\/doi.org\/10.1111\/jdv.14095.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1287_CR26","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2215\/cjn.05490610","volume":"6","author":"E Balaskas","year":"2011","unstructured":"Balaskas E, Szepietowski JC, Bessis D, et al. Randomized, double-blind study with glycerol and paraffin in uremic xerosis. Clin J Am Soc Nephrol. 2011;6(4):748\u201352. https:\/\/doi.org\/10.2215\/cjn.05490610.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1287_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2230.1996.tb00118.x","volume":"21","author":"C El Gammal","year":"1996","unstructured":"El Gammal C, Pagnoni A, Kligman AM, el Gammal S. A model to assess the efficacy of moisturizers\u2014the quantification of soap-induced xerosis by image analysis of adhesive-coated discs (D-Squames\u00ae). Clin Exp Dermatol. 1996;21(5):338\u201343.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1287_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1467-2494.2000.00002.x","volume":"22","author":"JM Lagarde","year":"2000","unstructured":"Lagarde JM, Black D, Gall Y, Del Pozo A. Image analysis of scaly skin using Dsquame\u00ae samplers: technical and physiological validation. Int J Cosmet Sci. 2000;22(1):53\u201365. https:\/\/doi.org\/10.1046\/j.1467-2494.2000.00002.x.","journal-title":"Int J Cosmet Sci"},{"issue":"3","key":"1287_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"issue":"3","key":"1287_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x.","journal-title":"Clin Exp Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01287-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T03:15:49Z","timestamp":1731467749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01287-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01287-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Revised version of figure 2 updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jacek Szepietowski has served as a consultant and\/or advisor for AbbVie, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Sanofi-Genzyme, Trevi, UCB, and Vifor; a speaker for AbbVie, Almirall, Eli Lilly, Janssen-Cilag, LEO Pharma, Novartis, Pfizer, and Sanofi-Genzyme; and an investigator for AbbVie, Almirall, Amgen, AnaptysBio, BMS, Boehringer Ingelheim, Celtrion, Galapagos, Galderma, HELM AG, Incyte, InfraRx, Janssen-Cilag, Kiniksa, LEO Pharma, MedImmune, Menlo Therapeutics, Merck, Novartis, Pfizer, Pierre Fabre, Regeneron, Teva, Trevi, and UCB. Lajos Kemeny and Thomas Mettang have no conflicts of interest to declare. Petr Arenberger has served as a consultant and\/or advisor for AbbVie, BMS, LEO Pharma, Novartis, Pfizer, Pierre Fabre, MSD, Sanofi, and UCB; and a speaker for AbbVie, Almirall, BMS, Johnson and Johnson, LEO Pharma, Novartis, MSD, and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki, International Conference on Harmonisation Good Clinical Practice Guidelines, and applicable local laws. The study protocol was approved in each country by applicable independent ethics committees and competent authorities (Supplementary Table\u00a0), and written informed consent was obtained from all participants. This study is registered with ClinicalTrials.gov (NCT01084148) and the European Union Clinical Trials Register (EudraCT 2006-002201-31).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}